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Abstract
High-resolution metabolomics has created opportunity to integrate nutrition and metabolism
into genetic studies to improve understanding of the diverse radiation of primate species. At
present, however, there is very little information to help guide experimental design for study
of wild populations. In a previous non-targeted metabolomics study of common marmosets
(Callithrix jacchus), Rhesus macaques, humans, and four non-primate mammalian species,
we found that essential amino acids (AA) and other central metabolites had interspecies
variation similar to intraspecies variation while non-essential AA, environmental chemicals
and catabolic waste products had greater interspecies variation. The present study was
designed to test whether 55 plasma metabolites, including both nutritionally essential and
non-essential metabolites and catabolic products, differ in concentration in common mar-
mosets and humans. Significant differences were present for more than half of the metabo-
lites analyzed and included AA, vitamins and central lipid metabolites, as well as for
catabolic products of AA, nucleotides, energy metabolism and heme. Three environmental
chemicals were present at low nanomolar concentrations but did not differ between species.
Sex and age differences in marmosets were present for AA and nucleotide metabolism and
warrant additional study. Overall, the results suggest that quantitative, targeted metabolo-
mics can provide a useful complement to non-targeted metabolomics for studies of diet and
environment interactions in primate evolution.
Introduction
Studies of primate genetics, nutrition and social behaviors have considerably advanced under-
standing of primate evolution [1–5], yet understanding of impact of diet and environmental
factors affecting metabolism, such as water and food availability, infections, and predation, is
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incomplete. In recent years, metabolomics methods have become available, but metabolic stud-
ies of wild populations are challenging because of variable and non-uniform diets as well as
unknown effects of age, sex, infections and threats of predation. Studies of captive primate col-
onies maintained for the study of health, aging and chronic disease provide an approach to
establish baseline information with relatively controlled diet and environmental threats.
Common marmoset (Callithrix jacchus) is a NewWorld monkey that belongs to the mono-
phyletic primate family Callitrichidae with characteristics of small size, early maturation and
relatively short lifespan [6, 7]. Among the Callitrichid family including marmosets, tamarins,
lion tamarins and Goeldi’s monkey, marmosets are more likely to feed extensively on gums.
Marmosets have dental adaptations to gouge trees and stimulate the flow of gum [8, 9], which
allowed marmosets to colonize drier forests and small forest fragments where there is little
fruit [10]. Laboratory marmosets are not a perfect model for wild animals because they tend to
maintain higher body weights (350–400 g) compared to marmosets in the wild (320–340 g) [6]
and are not exposed to their natural diet or habitat. Diet-dependent early-onset weight gain
and obesity also occur with laboratory diets fed to marmosets [11] and progress is ongoing to
improve captive management through development of evidence-based, standardized proce-
dures for diet and feeding husbandry [11–16]. An earlier study by Tardif et al. also showed that
infant-care factors such as being off carrier and weaning significantly affected growth rate of
common marmosets suggesting that diet and social system are critical factor for metabolic con-
trol [17].
In a previous study, we used non-targeted metabolomics to compare metabolism of com-
mon marmoset (Callithrix jacchus) to six other mammalian species including Rhesus macaque,
humans, and four non-primate mammalian species [18]. This non-targeted analysis using liq-
uid chromatography and high-resolution mass spectrometry enables measurement of metabo-
lites in 146 out of 154 metabolic pathways in the Kyoto Encyclopedia of Genes and Genomes
(KEGG) database in a single analysis [19, 20]. This information-rich metabolic data can be
combined with genomic or proteomic changes to provide an integrated perspective of biologi-
cal phenotypes and improve understanding of the natural biology of organisms as well as the
metabolic basis of disease. Tools are becoming available to address the complexities of omics
data and the demanding biostatistical and bioinformatics for their interpretation [21]. Accu-
mulating data with clinical and animal studies show metabolic alterations associated with mul-
tiple diseases of potential interest concerning primate biology, such as infectious diseases [22–
24], diabetes [25], eye diseases [26], cardiovascular disease [27] and environmental toxicities
[28].
In the comparative study of mammalian species, we found that even though humans have
relatively uncontrolled environments compared to animals in research facilities, a similar num-
ber and diversity of chemicals was found in plasma. In an effort to identify plasma metabolites
that could be useful for comparative biochemistry and toxicology research, we applied proba-
bility-based modularity clustering to identify metabolites with similar inter-species and intra-
species variation. Results showed that metabolite patterns were most similar within species and
separated primates from other mammalian orders and families. Importantly, these characteris-
tics suggest that quantitative differences in metabolite concentrations between species could
provide useful information about nutrition and metabolism as determinants of primate
evolution.
In the present study, we used a targeted metabolomics approach to test whether 55 plasma
metabolites, including both nutritionally essential AA and non-essential metabolites and cata-
bolic products, differ in concentration between common marmosets and humans. These were
selected to include common clinical measures of disease (glucose, creatinine, urea, bilirubin),
water-soluble vitamins (riboflavin, thiamin, niacin, niacinamide, pyridoxine, pyridoxamine,
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chromatography-mass spectrometry; m/z, mass-to-
charge; rt, retention time.
pyridoxal, pantothenic acid and biotin), amino acids and related metabolites, lipid-related
metabolites (choline, betaine, dimethylglycine, carnitine, acetylcarnitine, sphingosine, sphinga-
nine), nucleotide metabolites (hypoxanthine uric acid, allantoin) and environmental chemicals
(flame retardant, triethylphosphate; an insecticide, pirimicarb; a plasticizer, dibutylphthalate).
A multivariate analysis of covariance (MANCOVA) was further used to determine whether
abundance of metabolites was affected by age, sex, body mass. The analytic methods with liquid
chromatography and high-resolution mass spectrometry are similar to non-targeted metabolo-
mics but have an advantage in supporting absolute quantification rather than relative quantifi-
cation [19, 20]. In principle, the quantitative methods tested here can be extended to measure
metabolites in 146 out of 154 metabolic pathways in the Kyoto Encyclopedia of Genes and
Genomes (KEGG) database [21] and thereby provide functional measures to complement
genomic studies. For the study, plasma from 50 captive marmosets was collected during rou-
tine health examination, and plasma metabolomics results were compared to plasma values for
80 humans [29].
Materials and Methods
Ethics Statement
This study complied with protocol approved by Harvard Medical School’s Standing Committee
and Harvard Medical School’s Internal Animal Care and Use Committee for this specific
study, and was not a general set of protocols. All procedures followed the American Society of
Primatologists’ Principles for the Ethical Treatment of Nonhuman Primates. No animals were
sacrificed as a result of the present study. This study contains original research on plasma
metabolomics of common marmosets.
Animals and Housing
Common marmosets (Callithrix jacchus) ranging in age from 2 to 15 years were maintained at
the New England Primate Research Center (Southborough, MA, USA), an AAALAC-accred-
ited facility, in accordance with the Guide for Care and Use of Laboratory Animals (“The
Guide”) [30]. Colony animals were maintained under an animal holding and breeding protocol
approved by Harvard Medical School’s Standing Committee on Animals; husbandry of the col-
ony was described previously [31, 32]. The animals were fed commercial marmoset food (New
World Primate Chow 8791, Harlan Teklad, Indianapolis, IN, USA), supplemented daily with a
combination of fresh fruits, vegetables, seeds, eggs and/or mealworms. The animals had water
ad libitum in polycarbonate water bottles. Animals were pair housed [standard cage, 5.8 ft2
(0.54 m2) of floor space, 2.7 ft (0.82 m) of height and equates to 15.7 ft3 (0.45 m3) of volume] or
group housed in family units [aviary style cage, maximum of 9 individuals, 11.9 ft2 (1.10 m2) of
floor space, 5.2 ft (1.58 m) of height and equates to 61.9 ft3 (1.75 m3) of volume]. In very rare
instances, colony animals may have been temporarily housed singly for clinical reasons or
while a suitable cage mate was identified. Caging, comprised of stainless steel mesh, met or
exceeded the cage size requirements proposed by “The Guide” when “overall cage volume and
linear perch space” were considered [30]. In addition to social housing, environmental enrich-
ment consisted of cage fixtures for perching and hiding, nesting boxes, manipulanda, foraging
opportunities, classical music and other veterinary approved auditory stimuli, positive human
interaction, and others. Blood samples were collected during a quarterly physical examination;
animals were sedated with 0.2 mL of ketamine given intramuscularly. Blood was collected in
EDTA-containing evacuated tubes; plasma was separated, frozen, shipped on dry ice and main-
tained at −80°C until analysis.
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Metabolite Analysis by Liquid Chromatography-Mass Spectrometry
(LC-MS)
Metabolites were analyzed by LC-MS using external calibration with authentic standards [20].
Briefly, 50 μL of plasma was added to 100 μL of acetonitrile and 2.5 μL of a mixture of 14 stable
isotope standards. Samples were mixed, incubated at 4°C for 30 min, and centrifuged to
remove proteins. Supernatants of samples were analyzed in triplicate by LC-MS [20, 33]. Data
were extracted using apLCMS [16] with modifications by xMSanalyzer [34] asm/z features,
where anm/z feature is defined bym/z (mass-to-charge ratio), rt (retention time) and ion
intensity, and provided in the Supporting Information file (S1 Table). Metabolite identities
were confirmed via rt relative to authentic chemicals and ion dissociation mass spectrometry
(MS/MS) with fragmentation patterns matching those of authentic chemicals or those available
from online databases, e.g., Scripps Center for Metabolomics (https://metlin.scripps.edu/index.
php) and Human Metabolome Database (http://www.hmdb.ca/). Concentrations are expressed
as mean ± standard deviation (SD) except as labeled otherwise.
Human Metabolite Concentration Data
The data of human metabolites were obtained using the same methods as described for mar-
mosets. Data for the present study were derived from EDTA plasma samples from 80 healthy
humans analyzed as part of an ongoing healthy aging study (A.A. Quyyumi, Emory IRB proto-
col # IRB00024767)[29]. The study included individuals between 30 and 90 y, with even distri-
bution of sex, and included individuals of different races and ethnicities present in the Atlanta
area. All individuals were extensively screened to assure good health in terms of the absence of
disease markers and absence of therapeutic drug use. Because the samples were de-identified
and analysis was randomized and blinded, no additional details are available. Plasma was
stored at -80°C before LCMS analysis. Additional reference values for many of the metabolites
are available from HMDB (http://www.hmdb.ca/metabolites).
Metabolic Pathways Analysis Using Kyoto Encyclopedia of Genes and
Genomes (KEGG)
Quantitatively different metabolites were visualized in KEGG metabolic pathway analysis
(http://www.genome.jp/kegg/pathway.html#metabolism).
Statistics
For ANOVA (StatPlus) comparisons according to age and sex, the assumption of equal vari-
ances was evaluated using Levene's test of homogeneity. For each metabolite except Phe, the
equal variance assumption was satisfied. For Phe, the equal variance assumption was met
after Log2 transformation. Following two-way ANOVA, comparisons among groups within
each factor were compared using Scheffe contrast among pairs of means with p<0.05. Figures
were generated using OriginLab (OriginLab Corporation, Northampton, MA, USA). To test
the effect of age, sex, mass and their interaction on the abundance levels of metabolites,
MANCOVA based on the Pillai-Bartlett statistic was performed on 45 metabolites of 50 mar-
mosets simultaneously. The MANCOVA analysis was performed using the manova function
in R. This was followed by univariate ANCOVA tests to explore the effects of individual
features.
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Results
Age
Analyses were performed on 24 females and 26 males from 2 to 15 y. The marmosets were
healthy with no difference in age (females, 7.8 ± 4.0 y; males, 8.0 ± 3.9 y; p = 0.8). The mean
ages of younger (4.5 ± 1.8 y) and older (11.1 ± 2.5 y) females were comparable to those of youn-
ger (4.5 ± 1.8 y) and older (11.1 ± 2.3 y) males.
Body Mass
The mean body mass of 50 marmosets was 400 ± 44 g (female, 404± 50 g; male, 396± 39 g)
with range from 323 g to 535g [n = 40 (female = 18, male = 22)< 435 g; n = 10 (female = 6,
male = 4)> 435g].
Clinical Measures
Plasma glucose was 4.01 ± 1.44 mM, not significantly different from humans and similar to
HMDB human values (Table 1). Cortisol (10.2 ± 4.1 μM) and cortisone (0.51 ± 0.19 μM) were
significantly higher than human values, as previously shown [35]. Values for creatinine
(83 ± 24 μM) and urea (4.69 ± 2.15 mM), indicators of renal function, were significantly lower
than human values (Table 1) but within normal ranges for human values in HMDB. Creatine
was not significantly different from human values. Bilirubin (1.8 ± 1.1 μM), a measure that is
increased with liver dysfunction, was significantly lower than human values (5.7 ± 6.4 μM).
Water-Soluble Vitamins
Plasma levels of water-soluble vitamins (riboflavin, thiamin, niacin, niacinamide, pyridoxine,
pyridoxamine, pyridoxal, pantothenic acid and biotin) in marmosets overlapped with HMDB
values for humans (Table 1), but riboflavin, nicotinamide, pyridoxine, pyridoxamine, panto-
thenate and biotin were significantly different between marmosets and humans (Table 1).
Amino Acids
As previously reported [33], the mean phenylalanine (Phe) concentration in plasma
(271 ± 151 μM) was substantially higher than mean values for human plasma (47 ± 15 μM)
and reference HMDB values (44 to 88 μM) (Fig 1A, Table 1). Mean plasma methionine (Met)
was also significantly higher (Fig 1B, and respective mean values for arginine (Arg), histidine
(His) and leucine/isoleucine (Leu/Ile), were significantly lower than human values (Fig 1C–1F,
Table 1). Mean plasma threonine and tryptophan (Trp) values were within the range of mean
values summarized in HMDB for humans but were significantly different in the direct compar-
ison (Table 1). With the exception of taurine, which was higher in marmosets, all of the non-
essential amino acids that were measured in marmoset plasma were not significantly different
from human values and within the range of values summarized in HMDB for humans. Mean
value for tyrosine (Fig 1G) was not significantly different from measured human values but
was below the range of values in HMDB (Table 1).
Amino Acid Metabolites
Five metabolites of Trp were measured, and all were significantly higher than values in humans
(Table 1). Four Phe metabolites were quantified; phenylacetate and methylphenylpropionate
were not different from human values, homogentisate (0.15 ± 0.09 μM) was higher than
humans (0.02 ± 0.01 μM) and methyphenyllactate (14 ± 7 μM) was lower than humans
Marmoset Metabolic Characterization
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Table 1. Plasmametabolite concentrations in commonmarmosets.
Metabolite m/z rt Marmosets Mean±SD HumansMean±SD Human metabolomics Database
Health indicators
Glucose (mM) 203.0512 57 4.0 ± 1.4 4.0±0.9 3.9 to 6.1
Creatine (μM) 132.0759 52 38 ± 15 52±35 8.4 to 65
Creatinine (μM) 114.0905 393 83 ± 24 102±16* 56 to 109
Urea (mM) 121.0711 58 4.7 ± 2.1 3.2±1.6* 4 to 9
Cortisol (μM) 363.2143 160 10.2 ± 4.1 0.49±0.25* 0.028 to 0.66
Cortisone (μM) 361.1991 174 0.51 ± 0.19 0.010±0.004* 0.022 to 0.075
Bilirubin (μM) 585.2668 350 1.9 ± 1.1 5.7 ± 6.4* 8 to 15
Vitamins and Coenzymes
Riboﬂavin (nM) 377.1468 215 6.0 ± 5.7 15.5 ± 0.02* 5.4 to 28
Thiamine (μM) 265.1164 69 0.64 ± 0.62 0.39 ± 0.3 0.09 to 0.28
Niacin; nicotinic acid (μM) 124.0398 45 17.5 ± 7.0 29.8 ± 29.0 43 to 55
Nicotinamide (μM) 123.0544 326 0.43 ± 0.18 0.27 ± 0.15* 0.43 to 0.45
Methylnicotinic acid (nM) 138.0540 64 16 ± 9 20.0 ± 19.9 N/A
Pyridoxine (nM) 170.0714 61 59 ± 43 9.7 ± 6.1* 7 to 60
Pyridoxal (nM) 168.0643 93 230 ± 110 N/A 200 to 300
Pyridoxamine (nM) 169.0950 101 71 ± 56 0.14 ± 0.09* 126 to 202
Pantothenic acid (μM) 220.1761 231 4.1 ± 1.8 7.57 ± 7.22* 4.5 to 5.3
Biotin (nM) 245.0980 289 2.7 ± 1.1 4.5 ± 3.3* 0.6 to 1.9
Amino Acids
Arginine (μM) 175.1178 59 40 ± 29 72 ± 33* 60 to 140
Histidine (μM) 178.0575 51 71 ± 21 52 ±14* 75 to 143
Leucine/Isoleucine (μM) 176.0646 59 88 ± 43 156 ± 56* 155 to 355
Lysine (μM) 191.0755 48 104 ± 57 117 ± 41 178 to 434
Methionine (μM) 150.0568 79 39 ± 20 24 ± 6* 25 to 35
Phenylalanine (μM) 166.0851 57 271 ± 151 47 ± 15* 48 to 88
Threonine (μM) 120.0646 88 132 ± 39 103 ± 33* 102 to 260
Tryptophan (μM) 205.0958 56 72 ± 21 40 ± 11* 44 to 78
Asparagine (μM) 133.0679 92 18 ± 15 N/A 16 to 57
Citrulline (μM) 176.1018 63 34 ± 18 31 ± 14 27 to 38
Glutamate (μM) 148.0594 70 36 ± 25 23 ± 13 24 to 145
Glutamine (μM) 147.0758 56 553 ± 141 463 ± 317 490 to 645
Proline (μM) 116.0698 54 168 ± 62 195 ± 66 168 to 239
Taurine (μM) 148.0027 52 105 ± 37 32 ± 13* 42 to 162
Tyrosine (μM) 182.0799 58 44 ± 20 44 ± 11 54 to 143
Amino Acid Metabolites
5-Hydroxytryptophan (μM) 221.0907 62 0.41 ± 0.32 0.030 ± 0.012* 0.015 to 0.021
Indoleacrylic acid (μM) 188.0693 64 0.02 ± 0.01 0.01 ± 0.00* N/A
Indolelactate (μM) 206.0797 101 4.98 ± 1.67 0.72 ± 0.30* 0.5 to 5
3-Indolepropionic acid (μM) 190.0849 202 9.11 ± 5.33 0.04 ± 0.04* 0.29 to 1.09
Kynurenine (μM) 209.0914 73 3.68 ± 1.47 1.84 ± 0.72* 1.5 to 1.7
Phenylacetate (nM) 137.0586 216 2.7 ± 2.0 2.78 ± 2.15 N/A
Methylphenyllactate (nM) 181.0847 167 14 ± 7 48 ± 64* N/A
Methylphenylpropanoate (nM) 165.0899 257 8.0 ± 5.0 6.5 ± 3.8 N/A
Homogentisic acid (μM) 169.0436 106 0.15 ± 0.09 0.02 ± 0.01* 0.014 to 0.071
Oxoproline (μM) 130.0490 53 47 ± 11 62 ± 13* 13 to 161
Hippurate (μM) 180.0644 63 8.6 ± 5.8 6.6 ± 6.3 0 to 5
(Continued)
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(48 ± 64 μM). Mean plasma values for oxoproline (pyroglutamate) and aminobutyric acid sig-
nificantly differed between marmosets and humans, but the ranges for both overlapped sub-
stantially. The glycine metabolite of benzoic acid, hippuric acid, was not significantly different
between marmosets and humans.
Choline and Related Metabolites
Metabolites involved in 1-carbon metabolism, betaine and dimethylglycine, had values that
were comparable to human values in HMDB, but mean values were significantly different
when compared to measurements in humans (Table 1). In contrast, choline and carnitine
metabolites were approximately 10-fold lower than human values (Fig 2, Table 1). These
included data for marmosets and humans, respectively: choline 1.46 ± 0.51 μM, 8 to 13 μM;
carnitine 6.7 ± 2.2 μM, 26 to 79 μM; and acetylcarnitine 0.54 ± 0.30 μM, 3.2 to 7.6 μM. Sphin-
gosine (0.74 ± 0.33 μM) was significantly lower than humans (1.21 ± 0.38 μM) but the ranges
overlapped. Sphinganine was not significantly different between marmosets and humans.
Nucleotide Metabolites
Plasma uridine was higher than measured human values but similar to the HMDB range.
Hypoxanthine was within the HMDB range but was 10-fold higher than the values in humans
obtained with the same method. Uric acid concentration (84 ± 73 μM) was lower than values
for humans (238 to 506 μM). Allantoin was not measured in humans but was within the range
reported in HMDB (Table 1).
Table 1. (Continued)
Metabolite m/z rt Marmosets Mean±SD HumansMean±SD Human metabolomics Database
2-Aminobutyrate (nM) 104.0698 54 6.0 ± 4.0 4.6 ± 1.4* N/A
Lipid-Related Metabolites
Choline (μM) 104.1062 51 1.5 ± 0.5 0.85 ± 0.23* 8.7 to 12.5
Betaine (μM) 118.0854 54 123 ± 64 31 ± 13* 20 to 144
Dimethylglycine (μM) 104.0697 424 2.91 ± 0.75 2.28 ± 0.97* 1.8 to 3.7
Carnitine (μM) 162.1114 79 6.7 ± 2.2 66 ± 24* 26 to 79
Acetylcarnitine (μM) 204.1216 66 0.54 ± 0.30 N/A 3.2 to 7.6
Sphinganine (nM) 302.3034 331 4.8 ± 2.6 6.6 ± 6.3 11
Sphingosine (μM) 300.2877 510 0.74 ± 0.33 1.21 ± 0.38* 0.05 to 0.51
Nucleotide-Related Metabolites
Uridine (μM) 245.0757 95 2.11 ± 0.84 0.91 ± 0.68* 2.9 to 3.3
Hypoxanthine (μM) 137.0448 59 54 ± 34 3.9 ± 3.6* 1.3 to 54.5
Uric acid (μM) 169.0342 54 84 ± 73 214 ± 54* 238 to 506
Allantoin (μM) 159.0502 63 2.2 ± 1.1 N/A 1.0 to 3.2
Environmental Chemicals
Triethylphosphate (nM) 183.0768 382 14.5 ± 3.4 10.8 ± 9.5 N/A
Pirimicarb (nM) 239.1475 548 0.7 ± 0.4 0.80 ± 0.36 N/A
Dibutylphthalate (nM) 279.1573 381 3.0 ± 1.0 14.0 ± 44.4 N/A
Plasma metabolites of common marmosets (n = 50) quantiﬁed by LC-MS are included along with measures for human plasma (n = 80) obtained with the
same method. Ranges of concentrations of metabolites in human plasma reported by HMDB are also included for comparison. (m/z, mass-to-charge, rt,
retention time). N/A, data not available.
* Levels in common marmosets signiﬁcantly different from the levels in human, p < 0.05, following Bonferroni correction.
doi:10.1371/journal.pone.0142916.t001
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Environmental Chemicals
A previous comparative study of mammalian species detected environmental agents in mar-
moset plasma, including a flame retardant, triethylphosphate, an insecticide, pirimicarb, and a
plasticizer, dibutylphthalate. These chemicals were quantified and found to be present at
14.5 ± 3.4 nM, 0.7 ± 0.4 nM and 3.0 ± 1.0 nM, respectively, and were not significantly different
from human values. Respective concentrations for human plasma were not available in HMDB
Fig 1. Plasma levels of amino acids in commonmarmosets and human. Plasma of commonmarmosets
including female and male marmosets (n = 50) was analyzed for amino acids by LCMS to compare with
values of human plasma (H). Concentration of phenylalanine (A) and methionine (B), histidine (C) of common
marmoset (CM, mean ± SD) were significantly higher than human. Arginine (D) and leucine/isoleucine (E)
were significantly lower in CM than H. Lysine (F) and tyrosine (G) values of CM were not significantly different
from H (Mean ± SD). * p < 0.05.
doi:10.1371/journal.pone.0142916.g001
Fig 2. Choline and carnitine metabolites were lower in commonmarmoset than human. Using the
samemethod described in Fig 1, choline (A) and carnitine (B) in lipid category of commonmarmoset (CM)
were quantified and compared with human (H). Bar graphs showMean ± SD. * p < 0.05.
doi:10.1371/journal.pone.0142916.g002
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or anywhere else. A literature value for dibutylphthalate concentration in human serum, 4.4
nM [36], was also similar to the value found in marmosets.
Sex and Age-Dependent Differences in Marmoset Metabolites
Two-way ANOVA with post-hoc comparisons was performed for male and female marmosets
divided according to age (2 to 7 y and 8 to 15 y). This division was based upon the age range of
the colony and designed to give comparable numbers of older and younger animals. Data are
provided in Table 2. To allow adjustment for body mass, MANCOVA and ANCOVA were
also performed with age, sex and body mass. For these analyses, the R package limited the max-
imal number of metabolites that could be included to 45; thus, MANCOVA and ANCOVA
analyses were performed without the lowest abundance groups of chemicals, i.e., vitamin
metabolites and environmental chemicals. MANCOVA showed p values reflecting a trend for
sex (p = 0.075) and age (p = 0.092), but not for body mass (p = 0.84). ANCOVA data are pro-
vided in Table 3. For simplicity, differences according to sex are discussed first followed by dif-
ferences according to age. ANCOVA showed only three metabolites significantly associated
with body mass after adjusting for sex and age; these were urea, kynurenine and homogentisate
(Table 3).
A small number of metabolites were significantly different between males and females by
ANOVA; Fig 3 shows metabolites higher in females and Fig 4 shows metabolites higher in
males. These include some essential amino acids (Lys, Met and Phe in Fig 3; Trp in Fig 4), a
non-essential amino acid (glutamate, Glu; Fig 3), amino acid metabolites (indoleacrylic acid,
methylphenylpropanoate; Fig 4), a protein nitrogen degradation product (urea, Fig 4) and a
pyrimidine metabolite, uridine. Other amino acids (His, citrulline) were not significantly
higher in females but had p<0.1, indicating a trend. A vitamin essential for amino acid metab-
olism (pyridoxine) was not significantly higher in males, but also had p<0.1, indicating a
trend. Sphingosine and sphinganine were not significantly different but had p<0.1, indicating
a trend for sphingosine to be higher in males and sphinganine to be higher in females. No dif-
ferences were apparent for the environmental chemicals that were measured. Analysis using
ANCOVA showed that uridine was significantly different by sex after adjusting for age and
body mass (Table 3). Other metabolites that were significant by ANOVA were also significant
by ANCOVA, except lysine, which lost significance after adjusting for age and body mass.
With ANOVA, no differences were observed with age for amino acids or environmental
chemicals. Three amino acid metabolites (oxoproline, dimethylglycine and hippurate) were
higher in older marmosets in both females and males (Fig 5A–5C, Table 2). Two metabolites
functioning in fatty acid metabolism by mitochondria, carnitine and acetylcarnitine, had
p = 0.069 and p = 0.060, respectively, indicating trends to be higher in the older animals; espe-
cially, acetylcarnitine was significantly higher (p<0.05) in older females than younger females.
Hypoxanthine, a purine metabolite, and cortisone, a stress hormone, were lower in older mar-
mosets (Fig 5D and 5E, Table 2).
With adjustment for sex and body mass in ANCOVA, Trp and Gln were significantly asso-
ciated with age (Table 3). In addition to the amino acid metabolites that were significant by
ANOVA, 5-hydroxytryptophan, indoleacrylic acid, 3-indolepropionic acid and homogentisate,
differed by age after adjustment for sex and body mass. ANCOVA also showed carnitine and
acetylcarnitine, as well as hypoxanthine, were different by age after adjustment for sex and
body mass (Table 3).
Sex differences for young marmosets were significant for urea, Lys, Met, Phe, Trp, indo-
leacrylic acid, methylphenylpropanoate, sphingosine and sphinganine (Table 2). Sex differ-
ences for older marmosets were significant for urea, Met, Phe, Glu, uridine and allantoin.
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Table 2. Marmoset plasmametabolite concentrations according to age group and sex.
Metabolite Females<8 y Females 8 y Males <8y Males 8y
Clinical measures
Glucose (mM) 4.8 ± 1.8a 4.1 ± 1.1 3.5 ± 1.3a 3.8 ± 1.4
Creatine (μM) 31 ± 13 43 ± 12 38 ± 11 42 ± 20
Creatinine (μM) 74 ± 16 89 ± 34 88 ± 26 81 ± 18
Urea (mM) 3.7 ± 2.0a 3.7 ± 1.3b 5.5 ± 2.4a 5.7 ± 2.1b
Cortisol (μM) 11 ± 4 9 ± 5 11 ± 3 10 ± 4
Cortisone (μM) 0.59 ± 0.24 0.45 ± 0.16 0.57 ± 0.13d 0.44 ± 0.16d
Bilirubin (μM) 2.0 ± 1.1 2.1 ± 1.0 1.5 ± 0.8 1.9 ± 1.3
Vitamins and Coenzymes
Riboﬂavin (nM) 5 ± 5 11 ± 10 4 ± 4 6 ± 4
Thiamine (μM) 0.61 ± 0.37 0.95 ± 0.81 0.37 ± 0.27 0.57 ± 0.68
Niacin; nicotinic acid (μM) 17 ± 6 19 ± 6 19 ± 10 15 ± 4
Nicotinamide (μM) 0.42 ± 0.23 0.46 ± 0.17 0.41 ± 0.16 0.42 ± 0.18
Methylnicotinic acid (nM) 20 ± 10 14 ± 6 17 ± 11 14 ± 6
Pyridoxine (nM) 33 ± 14 57 ± 39 63 ± 37 76 ± 57
Pyridoxal (nM) 0.19 ± 0.09 0.25 ± 0.12 0.28 ± 0.11 0.20 ± 0.10
Pyridoxamine (nM) 87 ± 83 61 ± 25 57 ± 39 75 ± 57
Pantothenic acid (μM) 4.2 ± 0.9 3.5 ± 2.1 4.0 ± 1.4 4.5 ± 2.4
Biotin (nM) 3.1 ± 1.4 2.5 ± 1.1 2.9 ± 1.2 2.2 ± 0.7
Amino Acids
Arginine (μM) 35 ± 28 43 ± 28 32 ± 21 48 ± 36
Histidine (μM) 74 ± 27 81 ± 21 59 ± 14 72 ±19
Leucine/Isoleucine (μM) 99 ± 41 93 ± 58 87 ± 37 74 ± 33
Lysine (μM) 129 ± 82a 117 ± 48 76 ± 28a 96 ± 49
Methionine (μM) 47 ± 23a 49 ± 22b 29 ± 13a 32 ± 15b
Phenylalanine (μM) 348 ± 141a 404 ± 158b 167 ± 61a 180 ± 62b
Threonine (μM) 146 ± 58 135 ± 33 125 ± 31 124 ± 29
Tryptophan (μM)e 60 ± 20a 69 ± 19 90 ± 13a,d 71 ± 19d
Asparagine (μM) 16 ± 8 12 ± 11 23 ± 17 18 ± 18
Citrulline (μM) 35 ± 19 42 ± 17 32 ± 12 29 ± 20
Glutamate (μM) 216 ± 131 296 ± 180b 138 ± 83 138 ± 82b
Glutamine (μM) 509 ± 135 582 ± 168 519 ± 125 594 ± 130
Proline (μM) 169 ± 71 194 ± 58 158 ± 50 155 ± 67
Taurine (μM) 102 ± 43 107 ± 30 101 ± 35 110 ± 42
Tyrosine (μM) 45 ± 19 53 ± 20 41 ± 16 39 ± 22
Amino Acid Metabolites
5-Hydroxytryptophan (μM) 0.35 ± 0.19 0.56 ± 0.52 0.31 ± 0.16 0.42 ± 0.27
Indoleacrylic acid (μM)e 13 ± 5a 15 ± 5 20 ± 4a,d 14 ± 4d
Indolelactate (μM) 4.9 ± 2.2 4.7 ± 1.0 5.3 ± 1.3 5.0 ± 2.0
3-Indolepropionic acid (μM) 9.5 ± 3.8 8.5 ± 6.8 9.8 ± 3.7 8.7 ± 6.6
Kynurenine (μM) 4.1 ± 1.9 3.4 ± 1.1 3.6 ± 1.4 3.6 ± 1.5
Phenylacetate (nM) 3.3 ± 1.9 2.8 ± 1.7 1.7 ± 1.5 2.8 ± 2.5
Methylphenyllactate (nM) 12 ± 5 15 ± 8 12 ± 6 17 ± 8
Methylphenylpropanoate (nM) 6.2 ± 3.8a 5.5 ± 2.4 10.9 ± 5.0a 9.0 ± 6.0
Homogentisic acid (μM) 139 ± 77 198 ± 119 113 ± 62 143 ± 100
Oxoproline (μM) 42 ± 8c 50 ± 13c 45 ± 7 50 ± 12
Hippurate (μM) 6.1 ± 2.6c 11.8 ± 8.7c 7.3 ± 4.2 9.2 ± 4.8
(Continued)
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Age differences for females included oxoproline, hippurate, carnitine, uridine, hypoxanthine
and allantoin. Of these, oxoproline, hippurate and carnitine were higher in the older females
while uridine, hypoxanthine and allantoin were lower in the older females. Age differences for
males included cortisone, Trp, indoleacrylic acid, dimethylglycine, sphingosine and hypoxan-
thine. Of these, only dimethylglycine was increased in the older males; Trp, indoleacrylic acid,
sphingosine and hypoxanthine were decreased in older males.
Interactions between sex and age were seen for Trp, indoleacrylic acid and allantoin by
ANOVA, but only Trp and indoleacrylic acid were significant by ANCOVA. ANCOVA also
showed significant sex and body mass interactions for His, Trp, Glu, betaine and uridine, and
significant age and body mass interactions for creatinine, indoleacrylic acid and indolelactate.
Significant interaction of sex, age and body mass was observed for phenylacetic acid (Table 3).
Metabolic Pathways Associated with Metabolites that Are Different by
Species, Sex and Age
Amino acid differences were studied in detail for 6 primate species [37] and are converted to
common units for comparison to marmosets in Table 4. Results show that average values for
the aromatic amino acids Trp and Phe in marmoset plasma are higher than corresponding val-
ues for any of the other primate species, while arginine, asparagine and threonine values are
lower than other primate species.
Metabolic pathways were visualized using KEGG pathway analysis for quantitatively differ-
ent metabolites for age and sex. These include several amino acids and amino acid metabolites
Table 2. (Continued)
Metabolite Females<8 y Females 8 y Males <8y Males 8y
2-Aminobutyrate (nM) 5.3 ± 3.3 8.0 ± 5.4 6.7 ± 2.7 5.5 ± 2.4
Lipid-Related Metabolites
Choline (μM) 1.4 ± 0.5 1.6 ± 0.5 1.3 ±0.5 1.5 ± 0.5
Betaine (μM) 139 ± 76 141 ± 79 116 ± 48 99 ± 45
Dimethylglycine (μM) 2.6 ± 0.9 2.9 ± 0.6 2.7 ± 0.7d 3.3 ± 0.7d
Carnitine (μM) 5.4 ± 1.4c 7.9 ± 2.6c 6.2 ± 1.9 7.0 ± 2.3
Acetylcarnitine (μM) 0.45 ± 0.15 0.57 ± 0.26 0.45 ± 0.22 0.65 ± 0.44
Sphinganine (nM) 6.0 ± 2.1a 5.0 ± 2.5 3.5 ± 2.6a 4.9 ± 2.7
Sphingosine (μM) 0.69 ± 0.34a 0.62 ± 0.33 1.00 ± 0.27a,d 0.69 ± 0.29d
Nucleotide-Related Metabolites
Uridine (μM) 2.0 ± 0.7c 1.4 ± 0.6b,c 2.5 ± 0.9 2.4 ± 0.7b
Hypoxanthine (μM) 72 ± 40c 41 ± 20c 65 ± 40d 39 ± 21d
Uric acid (μM) 110 ± 120 60 ± 38 78 ± 41 78 ± 50
Allantoin (μM)e 2.7 ± 0.9c 1.5 ± 0.8b,c 2.0 ± 1.1 2.4 ± 1.4b
Environmental Chemicals
Triethylphosphate (nM) 13.7 ± 3.7 14.8 ± 4.3 14.3 ± 2.7 15.0 ± 3.3
Pirimicarb (nM) 0.86 ± 0.49 0.63 ± 0.32 0.54 ± 0.33 0.73 ± 0.35
Dibutylphthalate (nM) 0.26 ± 0.14 0.25 ± 0.10 0.30 ± 0.13 0.33 ± 0.18
aSigniﬁcant between younger females and younger males
bSigniﬁcant between older females and older males
cSigniﬁcant between younger females and older females
dSigniﬁcant between younger males and older males
eSigniﬁcant sex by age interaction
doi:10.1371/journal.pone.0142916.t002
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Table 3. ANCOVA p-values on feature-by-feature basis for association with age, sex, and bodymass.
Metabolites Sex Age Mass Sex:Age Sex:Mass Age:Mass Sex:Age:
Glucose 0.6702 0.6762 0.2750 0.8249 0.2300 0.4465 0.4823
Creatine 0.5185 0.1417 0.1169 0.5240 0.6274 0.2144 0.5511
Creatinine 0.5040 0.5988 0.2240 0.2689 0.8801 0.0149 0.1387
Urea 0.0275 0.6168 0.0329 0.6850 0.2055 0.5565 0.2932
Cortisol 0.3917 0.0146 0.8398 0.9025 0.8167 0.4715 0.9400
Cortisone 0.7795 0.0036 0.2087 0.4746 0.7381 0.8159 0.8223
Bilirubin 0.3447 0.3378 0.3038 0.4172 0.2819 0.6744 0.4230
Arginine 0.8798 0.9302 0.2729 0.8844 0.8192 0.3855 0.7448
Histidine 0.1126 0.1081 0.5190 0.4284 0.0445 0.2957 0.3725
Leu/Ile 0.8572 0.5710 0.3407 0.3482 0.2384 0.3233 0.7540
Lysine 0.3137 0.4783 0.6965 0.1785 0.4159 0.9617 0.9369
Methionine 0.0032 0.3223 0.7058 0.4598 0.9862 0.9116 0.8842
Phenylalanine 0.0000 0.5352 0.6947 0.9600 0.1480 0.8879 0.7786
Threonine 0.2645 0.6217 0.9771 0.8287 0.5194 0.1060 0.1923
Tryptophan 0.0027 0.0477 0.1598 0.0135 0.0275 0.1748 0.2667
Asparagine 0.1116 0.3840 0.3398 0.8173 0.1481 0.2459 0.5809
Citrulline 0.1063 0.8311 0.4934 0.1053 0.7440 0.2792 0.2082
Glutamate 0.0018 0.1411 0.1187 0.2060 0.0320 0.7792 0.9008
Glutamine 0.6311 0.0465 0.5603 0.6394 0.8829 0.9432 0.2904
Proline 0.2502 0.8600 0.3103 0.4235 0.6924 0.7948 0.4435
Taurine 0.8139 0.8464 0.1289 0.6052 0.5907 0.4969 0.3662
Tyrosine 0.0847 0.3915 0.4905 0.1991 0.4870 0.0983 0.8035
5-Hydroxy-tryptophan 0.3844 0.0414 0.1108 0.7027 0.6525 0.4743 0.6012
Indoleacrylic acid 0.0277 0.0047 0.1709 0.0044 0.1104 0.0722 0.2440
Indolelactate 0.2353 0.5699 0.4865 0.6913 0.6157 0.0912 0.2744
3-Indole-propionic acid 0.8339 0.0228 0.4181 0.2743 0.1895 0.4770 0.6788
Kynurenine 0.6791 0.5554 0.0159 0.4220 0.1512 0.9392 0.6270
Phenylacetate 0.2585 0.1280 0.6268 0.1764 0.5340 0.4608 0.0448
Methylphenyl-lactate 0.7493 0.5574 0.8937 0.6992 0.9230 0.4890 0.5715
Methylphenyl-propanoate 0.0018 0.5249 0.7533 0.6030 0.4451 0.4576 0.5756
Homogentisic acid 0.2096 0.0272 0.0411 0.7161 0.6945 0.7880 0.9114
Oxoproline 0.4567 0.0694 0.3533 0.9628 0.8214 0.5262 0.3992
Hippurate 0.9654 0.0172 0.1716 0.9664 0.5540 0.9190 0.7350
2-Aminobutyrate 0.6061 0.7001 0.7046 0.2406 0.1440 0.7918 0.4595
Choline 0.4389 0.3375 0.2244 0.4195 0.7784 0.5934 0.7220
Betaine 0.1900 0.3131 0.2656 0.5522 0.0149 0.3690 0.0665
n,n-Dimethylglycine 0.1114 0.0161 0.1260 0.8903 0.1852 0.6146 0.7978
Carnitine 0.4672 0.0058 0.2663 0.3918 0.1193 0.8618 0.4059
Acetyl-carnitine 0.4454 0.0366 0.3640 0.5242 0.7539 0.5471 0.8175
Sphinganine 0.4601 0.6348 0.8071 0.1967 0.4718 0.8566 0.5940
Sphingosine 0.1616 0.3544 0.1126 0.3627 0.6510 0.1630 0.6425
Uridine 0.0005 0.1098 0.6389 0.3183 0.0233 0.5800 0.2985
Hypoxanthine 0.5886 0.0102 0.1947 0.8182 0.2342 0.5157 0.6802
Uric acid 0.4730 0.1708 0.3359 0.5365 0.3956 0.2830 0.9972
Allantoin 0.8965 0.1600 0.3685 0.1535 0.3038 0.6694 0.7520
doi:10.1371/journal.pone.0142916.t003
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Fig 3. Metabolites higher in female thanmale marmosets. Female and male marmosets were grouped
according to age as younger (y, 2 to 7 y) and older (o, 8 to 15 y). Following ANOVA, post-hoc tests showed
differences between groups as indicated by a, female versus male in younger marmosets; b, female versus
male in older marmosets. Group sizes were: females, 12 y, 12 o: males 13 y, 13 o.
doi:10.1371/journal.pone.0142916.g003
Fig 4. Metabolites higher in male than female marmosets. Female and male marmosets were grouped
according to age as younger (y, 2 to 7 y) and older (o, 8 to 15 y). Following ANOVA, post-hoc tests showed
differences between groups as indicated by a, female versus male in younger marmosets; b, female versus
male in older marmosets; c, younger versus older females; d, younger versus older males. Group sizes were:
females, 12 y, 12 o: males 13 y, 13 o.
doi:10.1371/journal.pone.0142916.g004
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Fig 5. Metabolites differing by age in marmosets. Female and male marmosets were grouped according
to age as younger (y, 2 to 7 y) and older (o, 8 to 15 y). A-C, metabolites higher in older than younger. D and E,
metabolites higher in younger than older. Following ANOVA, post-hoc tests showed differences between
groups as indicated: c, younger versus older females; d, younger versus older males. Group sizes were:
females, 12 y, 12 o: males 13 y, 13 o.
doi:10.1371/journal.pone.0142916.g005
Table 4. Amino acid comparisons between commonmarmosets and other primates.
Amino Acid Normalized
Marmoset Data
from Table 2 Mean
±SD
Human Mean value
(Table 2 value for
normalization)
Squirrel
Monkeys
Mean±SE
Stump-tailed
Macaques
Mean±SE
Rhesus
Monkey
Mean±SE
Talapoin
Monkeys
Mean±SE
Chimpanzees
Mean±SE
Arginine 42 ± 32 72 (80) 85 ± 15 86 ± 6 99 ± 11 85 ± 7 68 ± 5
Asparagine 12 ± 15 N/A (51) N/A 45 ± 2 42 ± 2 111 ± 9 41 ± 3
Citrulline 31± 16 31 (28) 35 ± 4 42 ± 6 26 ± 5 22 ± 2 25 ± 2
Glutamate 55± 38 23 (35) 188 ± 28 101 ± 12 93 ± 5 139 ± 10 61 ± 3
Glutamine 642 ± 164 463 (535) 904 ± 100 466 ± 46 468 ± 3 384 ± 18 389 ± 16
Histidine 105 ± 31 52 (77) 110 ± 8 88 ± 12 85 ± 3 99 ± 8 63 ± 3
Leucine/
Isoleucine
63 ± 31 156 (111) 113 ± 7 124 ± 14 114 ± 12 157 ± 18 60 ± 3
Lysine 152 ± 83 117 (171) 107 ± 13 186 ± 26 183 ± 16 194 ± 17 169 ± 10
Methionine 36 ± 18 24 (22) 60 ± 3 26 ± 3 18 ± 3 28 ± 1 20 ± 2
Phenylalanine 276 ± 154 47 (48) 69 ± 4 50 ± 4 52 ± 5 69 ± 2 46 ± 2
Proline 130 ± 48 195 (151) 176 ± 35 243 ± 38 179 ± 11 107 ± 9 218 ± 6
Taurine 158 ± 56 32 (48) 284 ± 70 205 ± 31 202 ± 12 287 ± 33 71 ± 6
Threonine 65 ± 19 103 (50) 178 ± 13 85 ± 8 82 ± 6 113 ± 10 97 ± 7
Tryptophan 95 ± 28 40 (53) 61 ± 7 36 ± 2 32 ± 3 40 ± 3 50 ± 3
Tyrosine 50 ± 23 44 (50) 72 ± 6 58 ± 4 40 ± 5 56 ± 3 52 ± 3
The original data of Peters et al, expressed as mg/dL, were converted to micromolar concentrations. To facilitate comparisons, marmoset data in this
Table were normalized based upon the human concentration for the respective amino acid in Table 2 (given in parentheses) and the corresponding value
provided by Peters et al. All concentrations are expressed as micromolar values.
doi:10.1371/journal.pone.0142916.t004
Marmoset Metabolic Characterization
PLOS ONE | DOI:10.1371/journal.pone.0142916 November 18, 2015 14 / 21
(Fig 6). Smaller numbers of other metabolites differed and included pathways for nucleotide
metabolism, lipid metabolism, and steroid hormone biosynthesis (Fig 6).
Discussion
Studies of conservation of genetic sequences has been very useful to understand evolution of
species; in principle, conservation of metabolic pathways and intermediate concentrations
could similarly provide useful information but has not been extensively developed. In our ear-
lier study of seven mammalian species, non-targeted plasma metabolomics showed greater
overlap of marmoset with rhesus macaques and humans than with rodentia and artiodactyla
[18]. That comparison was qualitative, however, based upon the number of common metabo-
lites detected. Although those metabolites detected matched metabolites in 137 out of 146 path-
ways in KEGG, more than half did not have matches to known chemicals in metabolomics
databases. In that study, we used probability-based modularity clustering as a means to analyze
chemicals according to the significance of their association with other chemicals [38]. By set-
ting criteria to classify chemicals according to significance of within-species correlations and
between-species correlations, a distribution was established in which modules of chemicals
that have similar variation among species were discriminated from chemicals that have greater
variation among species than within species. The results showed a large module enriched in
endogenous metabolites, including leucine/isoleucine, citrulline, cystine, other amino acids
and common intermediary metabolites. Another large module was enriched in environmental
chemicals (e.g., pirimicarb and di-N-butyl phthalate) and metabolites involved in chemical and
immunological defense (GSH, methionine and glutamine). Based upon this, we hypothesized
Fig 6. Visualization of metabolic pathways in marmosets that differed from ranges for human values
in HMDB.Quantitatively different metabolites were visualized in the KEGGmetabolic pathways. (http://www.
genome.jp/kegg/pathway.html#metabolism). Black squares indicate quantitatively different metabolites
matched in the metabolic pathways including lipid metabolism, amino acid metabolism, nucleotide
metabolism and steroid hormone biosynthesis.
doi:10.1371/journal.pone.0142916.g006
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that interspecies quantitative differences in central metabolites, metabolic degradation prod-
ucts and environmental chemicals, may be useful to improve understanding of speciation
among primates. However, this is experimentally difficult to test because of the need to have
large numbers of different species with good characterization of age, health and environmental
parameters.
The present study was designed to gain an understanding of quantitative differences
between marmosets and humans by measuring metabolites selected to include essential nutri-
ents and other central metabolites as well as metabolic degradation products and environmen-
tal chemicals. The results provide no support for the interpretation derived from the
probability-based modularity clustering that xenobiotics and non-essential metabolites will be
more useful for studies of speciation; in fact the results suggest the opposite, that central metab-
olites are likely to be most useful for studies of speciation. About half of the plasma metabolite
concentrations measured were significantly different when plasma samples were analyzed
using the same analytical platform. Thus, the data indicate that enough quantitative differences
exist to develop this approach as a complement to genetic studies of evolution.
Metabolites that differed between marmosets and humans included seven essential amino
acids, one non-essential amino acid, five amino acid metabolites, two metabolites involved in
1-carbon metabolism, bilirubin, and uric acid. These metabolites were visualized in KEGG
metabolic pathways (Fig 6) and mainly associated with amino acid metabolism and nucleotide
metabolism. These are important in protein metabolism, nitrogen balance and cellular turn-
over, and systematic analysis could therefore be useful in study of these aspects of the compara-
tive biology of primates. Additionally, differences in these pathways could be important in
understanding susceptibility to metabolic, renal, hepatic or other diseases.
In a recent untargeted metabolomics study to study the effect of a semi-synthetic, purified
diet on plasma metabolomics in marmosets [39], we found that methionine, leucine/isoleucine,
lysine and threonine were higher on the purified diet while phenylalanine was lower. These
results show that plasma metabolomics in marmosets is dependent upon diet so that prediction
of concentrations in wild populations cannot readily be made. As found earlier [33], the pres-
ent results show that Phe concentrations were higher in marmosets than in humans while
results obtained here show that Tyr is lower in humans and the degradation product, homo-
gentisate, is lower in marmosets. This could indicate that metabolism of Phe to Tyr is limited
in the captive population, as would occur with tetrahydrobiopterin insufficiency [40]. Alterna-
tively, genetic differences could occur between marmosets and humans in phenylalanine
hydroxylase activity. In contrast, Trp levels were comparable to human values but three metab-
olites of Trp (kynurenine, 5-hydroxytryptophan and indolepropionic acid) were higher in mar-
mosets. This result could be associated with ketamine used to sedate animals before blood
collection as described in method. The previous human metabolomics study showed that keta-
mine altered mitochondrial fatty acid metabolism in patients with bipolar depression [41], and
we also found that ketamine was strongly correlated with several metabolites associated with
Trp pathways in our metabolome-wide association study (MWAS) (unpublished data). The
effect of ketamine on marmoset metabolomics is currently under investigation. Trp metabo-
lism is complex because toxic metabolites can be generated by the microbiome [42], and Trp
serves as a precursor for seratonin [43], melatonin [44, 45] and niacin [46, 47], and also sup-
ports homeostasis of the immune system [48]. Because of the central roles of these metabolites
as precursors in signaling and immune defenses, these differences could be important in dis-
eases affecting marmosets. Additionally, Trp restriction has been linked to increased longevity
in rodents [49], indicating that studies of Trp utilization in marmosets may be useful to under-
stand associated mechanisms of aging.
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Plasma Met was also higher in marmosets than in humans. Met restriction has been associ-
ated with increased longevity, linked to essential amino acid balance and the mTOR pathway
[50, 51]. The Met product, homocysteine, has been linked to cardiovascular disease (CVD), but
efforts to protect against CVD by altering this pathway have been unsuccessful [52]. Met is also
an important precursor for S-adenosylmethionine synthesis and related methylation reactions
involved in detoxification and epigenetic mechanisms [53, 54], as well as functioning as a pre-
cursor for Cys, GSH and hydrogen sulfide generation [55, 56]. Met concentrations were higher
in females than males, and this was significant for younger and older marmosets. Related
metabolites functioning as 1-carbon donors, choline and carnitine, were lower in marmosets
than in humans but did not differ between females and males. Instead, carnitine and dimethyl-
glycine were higher in older marmosets. Thus, the data show a complex age and sex depen-
dency for Met and related 1-carbon metabolism, which will require more specific targeted
study.
Arg was lower and His was higher in marmosets than in humans. Both are required for pro-
tein synthesis; Arg is also a precursor for nitric oxide, polyamines, urea and creatine, and His is
a precursor for histamine. Additional studies will be needed to determine whether diet, genetics
or both account for the differences between species. The above discussion highlights differences
worthy of more detailed studies; overall, however, the data support the utility of marmosets for
use as a model for experimental investigation of mechanisms of aging and human disease. The
data show that all of the vitamin metabolites in marmosets overlapped with ranges found in
humans, but riboflavin, pantothenate and biotin were significantly lower and nicotinamide,
pyridoxine and pyridoxamine were higher. The data show that essential amino acid balances
differ from humans, suggesting that amino acid metabolism may be a critical area for research
on mechanisms of longevity in non-human primates. The data show that non-essential amino
acid concentrations are very similar to human values; only taurine differed significantly. Mea-
sures of bilirubin and uric acid show that marmosets effectively eliminate these metabolites;
significantly higher concentrations of uridine and hypoxanthine in marmosets suggest that
related metabolic pathways or transport systems may differ, perhaps reflecting adaptation of
marmosets to available habitat. Additionally, higher concentrations of carnitine and acetylcar-
nitine in older marmosets are consistent with extensive research implicating declining mito-
chondrial function in aging [57–59]. Of potential importance for carnitine, pathway analysis of
marmosets on a purified diet showed effects on carnitine metabolism [39], indicating that
changes in diet also impact related fatty acid metabolism.
How the results of this study on captive marmosets would compare to wild marmosets has
not been evaluated. Animal husbandry to assure health of animals in captivity includes optimi-
zation of diet, avoidance of stressful environmental conditions, and medically treating or
euthanizing sick animals. Because of this, complete agreement is not expected. On the other
hand, wild and captive marmosets differ in body mass, and the ANCOVA results showed that
body mass had little impact on which metabolites were significantly different according to sex
or age (Table 3). These results suggest that the physiologic differences between sexes and
between young and old marmosets may represent characteristics of the species and be useful
for validation of studies on wild populations. Metabolomics studies of wild marmosets are
needed to evaluate these differences.
In summary, quantification of 52 metabolites and 3 environmental chemicals in plasma of
common marmosets indicates that differences in metabolite concentrations may provide a use-
ful complement to non-targeted metabolomics for studies of diet and environment interactions
in primate evolution. Such data could provide a new dimension to studies of primate evolution
by allowing functional integration of the genome with environmental factors. Differences in
essential amino acid concentrations indicate that more detailed studies are needed to evaluate
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underlying factors, which could contribute to food utilization as well as health and aging. The
research highlights a need for studies of quantitative as well as non-targeted metabolomics to
advance understanding of the natural biology of primates.
Supporting Information
S1 Table. Metabolomics data of 50 common marmosets. Plasma collected from marmoset
was analyzed for metabolomics by high-resolution mass spectrometry as described in Methods.
The mass spectrometry data includes ion mass (mass to charge,m/z), retention time (sec) and
abundance (intensity) of 58 metabolites. The information of sex and age on 50 individuals is
indicated on top.
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